Optimal healthcare decisions: Comparing medical treatments on a cost-effectiveness basis

European Journal of Operational Research

Volumn 204, Issue 1, 2010, Pages 180-187

  Moreno, Elías ^a   Giron F J ^b   Vazquez Polo F J ^c   Negrin M A ^c  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF MÁLAGA   (Spain)

^c UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

Author keywords

Bayesian analysis; Cost effectiveness of a treatment; Healthcare; Net benefit; Optimal treatment; Treatments comparison; Utility functions

Indexed keywords

BAYESIAN; BAYESIAN ANALYSIS; COST EFFECTIVENESS ANALYSIS; DECISION SPACE; FIXED QUANTITY; FREQUENTIST; HEALTH-CARE DECISIONS; MEDICAL TREATMENT; OPTIMAL DECISION-RULE; OPTIMAL TREATMENT; UTILITY FUNCTIONS;

BAYESIAN NETWORKS; COST EFFECTIVENESS; COSTS; DECISION THEORY; GAME THEORY; HEALTH CARE; OPTIMIZATION;

COST BENEFIT ANALYSIS;

EID: 70449687710     PISSN: 03772217     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejor.2009.10.012     Document Type: Article

References (27)

1. Al M.J., and van Hout B.A. A Bayesian approach to economic analysis of clinical trials: the case of stenting versus balloon angioplasty. Health Economics (2000) 9; 599-609
2. Barton G.R., Briggs A.H., and Fenwick E.A. Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfect information (EVPI). Value in Health 11 5 (2008) 886-897
3. Berger J., and Bernardo J.M. On the development of reference priors. In: Bernardo J.M., Berger J., Dawid A.P., and Smith A.F.M. (Eds). Bayesian Statistics vol. 4 (1992), Oxford University Press, Oxford 35-60
4. Brailsford S., and Harper P. OR in health. European Journal of Operational Research 185 3 (2008) 901-904
5. Chalabi Z., Epstein D., McKenna C., and Claxton K. Uncertainty and valued of information when allocating resources within and between healthcare programmes. European Journal of Operational Research 191 2 (2008) 530-539
6. Claxton K., Lacey L.F., and Walker S.G. Selecting treatments: a decision theoretic approach. Journal of the Royal Statistical Society Series A 163 (2000) 211-225
7. Dalal S., and Hall W.J. Approximating priors by mixtures of natural conjugate prior. Journal of the Royal Statistical Society Series B 45 (1983) 278-286
8. Diaconis P., and Ylvisaker D. Quantifying prior opinion. In: Bernardo J.M., DeGroot M., Lindley D., and Smith A. (Eds). Bayesian Statistics vol. 2 (1985), North-Holland, Amsterdam 133-156
9. Drummond M.F., Sculpher M.J., Torrance G.W., O'Brien B.J., and Stoddart G.L. Methods for the economic evaluation of health care programmes. third ed. (2005), Oxford University Press, Oxford
10. Gelman A., Carlin J.B., Stern H.S., and Rubin D.B. Bayesian Data Analysis. second ed. (2004), Chapman & Hall, Boca Raton
11. Heitjan D.F., and Li H. Bayesian estimation of cost-effectiveness: an importance-sampling approach. Health Economics 13 (2004) 191-198
12. Hoch J., Rockx M.A., and Krahn A. Using the net benefit regression framework to construct cost-effectiveness acceptability curves: an example using data from a trial of external loop recorders versus Holter monitoring for ambulatory monitoring of "community acquired" syncope. BMC Health Services Research 6 (2006) 68
13. Nixon R., and Thompson S. Parametric modelling of cost data in medical studies. Statistics in Medicine 23 (2004) 1311-1331
14. O'Hagan A., and Stevens J.W. A framework for cost-effectiveness analysis from clinical trial data. Health Economics 10 (2001) 302-315
15. O'Hagan A., and Stevens J.W. Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies. Statistical Methods in Medical Research 11 (2002) 469-490
16. O'Hagan A., Stevens J.W., and Montmartin J. Bayesian cost-effectiveness analysis from clinical trial data. Statistics in Medicine 20 (2001) 733-753
17. Pendharkar P.C., and Rodger J.A. The relationship between software development team size and software development cost. Communications of the ACM 52 1 (2009) 141-144
18. Pinto J.L., López C., Badi{dotless}́a X., Coma A., et al. Análisis coste-efectividad del tratamiento antirretroviral de gran actividad en pacientes infectados por el VIH asintomáticos. Medicina Cli{dotless}́nica 114 3 (2000) 62-67
19. Spieglehalter D., Feedman L., and Parmar M. Bayesian approaches to randomized trials (with discussion). Journal of the Royal Statistical Society Series A 157 (1994) 357-416
20. Stinnett A.A., and Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Medical Decision Making 18 (1998) S68-S80
21. Thompson S., and Nixon R. How sensitive are cost-effectiveness analyses to choice of parametric distributions?. Medical Decision Making 25 (2005) 416-423
22. Vanness D.J., and Mullahy J. Perspectives on mean-based evaluation of health care. In: Jones A.M. (Ed). Elgar Companion to Health Economics (2006), Edward Elgar Publishing, Cheltenham 526-536
23. Vázquez-Polo F.J., Negri{dotless}́n M.A., Badi{dotless}́a X., and Roset M. Bayesian regression models for cost-effectiveness analysis. European Journal of Health Economics 50 (2005) 45-52
24. Weinstein M.C., and Manning Jr. W.G. Theoretical issues in cost-effectiveness analysis. Journal of Health Economics 16 (1997) 121-128
25. Willan A., and Briggs A.H. Statistical Analysis of Cost-effectiveness Data (2006), Wiley, Chichester
26. Willan A., and Kowgier M. Cost-effectiveness analysis of a multinational RCT with a binary measure of effectiveness and an interacting covariate. Health Economics 17 (2008) 777-791
27. Willan A., and Lin D.Y. Incremental net benefit in randomized clinical trials. Statistics in Medicine 20 (2001) 1563-1574